Cargando…

Precision Navigation of Hepatic Ischemia–Reperfusion Injury Guided by Lysosomal Viscosity-Activatable NIR-II Fluorescence

[Image: see text] Hepatic ischemia–reperfusion injury (HIRI) is responsible for postoperative liver dysfunction and liver failure. Precise and rapid navigation of HIRI lesions is critical for early warning and timely development of pretreatment plans. Available methods for assaying liver injury fail...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jihong, Zhang, Wen, Zhou, Chunmiao, Li, Mengmei, Wang, Xin, Zhang, Wei, Liu, Zhenzhen, Wu, Luling, James, Tony D., Li, Ping, Tang, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354259/
https://www.ncbi.nlm.nih.gov/pubmed/35793548
http://dx.doi.org/10.1021/jacs.2c03832
_version_ 1784763027456786432
author Liu, Jihong
Zhang, Wen
Zhou, Chunmiao
Li, Mengmei
Wang, Xin
Zhang, Wei
Liu, Zhenzhen
Wu, Luling
James, Tony D.
Li, Ping
Tang, Bo
author_facet Liu, Jihong
Zhang, Wen
Zhou, Chunmiao
Li, Mengmei
Wang, Xin
Zhang, Wei
Liu, Zhenzhen
Wu, Luling
James, Tony D.
Li, Ping
Tang, Bo
author_sort Liu, Jihong
collection PubMed
description [Image: see text] Hepatic ischemia–reperfusion injury (HIRI) is responsible for postoperative liver dysfunction and liver failure. Precise and rapid navigation of HIRI lesions is critical for early warning and timely development of pretreatment plans. Available methods for assaying liver injury fail to provide the exact location of lesions in real time intraoperatively. HIRI is intimately associated with oxidative stress which impairs lysosomal degradative function, leading to significant changes in lysosomal viscosity. Therefore, lysosomal viscosity is a potential biomarker for the precise targeting of HIRI. Hence, we developed a viscosity-activatable second near-infrared window fluorescent probe (NP-V) for the detection of lysosomal viscosity in hepatocytes and mice during HIRI. A reactive oxygen species–malondialdehyde–cathepsin B signaling pathway during HIRI was established. We further conducted high signal-to-background ratio NIR-II fluorescence imaging of HIRI mice. The contour and boundary of liver lesions were delineated, and as such the precise intraoperative resection of the lesion area was implemented. This research demonstrates the potential of NP-V as a dual-functional probe for the elucidation of HIRI pathogenesis and the direct navigation of HIRI lesions in clinical applications.
format Online
Article
Text
id pubmed-9354259
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-93542592022-08-06 Precision Navigation of Hepatic Ischemia–Reperfusion Injury Guided by Lysosomal Viscosity-Activatable NIR-II Fluorescence Liu, Jihong Zhang, Wen Zhou, Chunmiao Li, Mengmei Wang, Xin Zhang, Wei Liu, Zhenzhen Wu, Luling James, Tony D. Li, Ping Tang, Bo J Am Chem Soc [Image: see text] Hepatic ischemia–reperfusion injury (HIRI) is responsible for postoperative liver dysfunction and liver failure. Precise and rapid navigation of HIRI lesions is critical for early warning and timely development of pretreatment plans. Available methods for assaying liver injury fail to provide the exact location of lesions in real time intraoperatively. HIRI is intimately associated with oxidative stress which impairs lysosomal degradative function, leading to significant changes in lysosomal viscosity. Therefore, lysosomal viscosity is a potential biomarker for the precise targeting of HIRI. Hence, we developed a viscosity-activatable second near-infrared window fluorescent probe (NP-V) for the detection of lysosomal viscosity in hepatocytes and mice during HIRI. A reactive oxygen species–malondialdehyde–cathepsin B signaling pathway during HIRI was established. We further conducted high signal-to-background ratio NIR-II fluorescence imaging of HIRI mice. The contour and boundary of liver lesions were delineated, and as such the precise intraoperative resection of the lesion area was implemented. This research demonstrates the potential of NP-V as a dual-functional probe for the elucidation of HIRI pathogenesis and the direct navigation of HIRI lesions in clinical applications. American Chemical Society 2022-07-06 2022-08-03 /pmc/articles/PMC9354259/ /pubmed/35793548 http://dx.doi.org/10.1021/jacs.2c03832 Text en © 2022 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Liu, Jihong
Zhang, Wen
Zhou, Chunmiao
Li, Mengmei
Wang, Xin
Zhang, Wei
Liu, Zhenzhen
Wu, Luling
James, Tony D.
Li, Ping
Tang, Bo
Precision Navigation of Hepatic Ischemia–Reperfusion Injury Guided by Lysosomal Viscosity-Activatable NIR-II Fluorescence
title Precision Navigation of Hepatic Ischemia–Reperfusion Injury Guided by Lysosomal Viscosity-Activatable NIR-II Fluorescence
title_full Precision Navigation of Hepatic Ischemia–Reperfusion Injury Guided by Lysosomal Viscosity-Activatable NIR-II Fluorescence
title_fullStr Precision Navigation of Hepatic Ischemia–Reperfusion Injury Guided by Lysosomal Viscosity-Activatable NIR-II Fluorescence
title_full_unstemmed Precision Navigation of Hepatic Ischemia–Reperfusion Injury Guided by Lysosomal Viscosity-Activatable NIR-II Fluorescence
title_short Precision Navigation of Hepatic Ischemia–Reperfusion Injury Guided by Lysosomal Viscosity-Activatable NIR-II Fluorescence
title_sort precision navigation of hepatic ischemia–reperfusion injury guided by lysosomal viscosity-activatable nir-ii fluorescence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354259/
https://www.ncbi.nlm.nih.gov/pubmed/35793548
http://dx.doi.org/10.1021/jacs.2c03832
work_keys_str_mv AT liujihong precisionnavigationofhepaticischemiareperfusioninjuryguidedbylysosomalviscosityactivatableniriifluorescence
AT zhangwen precisionnavigationofhepaticischemiareperfusioninjuryguidedbylysosomalviscosityactivatableniriifluorescence
AT zhouchunmiao precisionnavigationofhepaticischemiareperfusioninjuryguidedbylysosomalviscosityactivatableniriifluorescence
AT limengmei precisionnavigationofhepaticischemiareperfusioninjuryguidedbylysosomalviscosityactivatableniriifluorescence
AT wangxin precisionnavigationofhepaticischemiareperfusioninjuryguidedbylysosomalviscosityactivatableniriifluorescence
AT zhangwei precisionnavigationofhepaticischemiareperfusioninjuryguidedbylysosomalviscosityactivatableniriifluorescence
AT liuzhenzhen precisionnavigationofhepaticischemiareperfusioninjuryguidedbylysosomalviscosityactivatableniriifluorescence
AT wululing precisionnavigationofhepaticischemiareperfusioninjuryguidedbylysosomalviscosityactivatableniriifluorescence
AT jamestonyd precisionnavigationofhepaticischemiareperfusioninjuryguidedbylysosomalviscosityactivatableniriifluorescence
AT liping precisionnavigationofhepaticischemiareperfusioninjuryguidedbylysosomalviscosityactivatableniriifluorescence
AT tangbo precisionnavigationofhepaticischemiareperfusioninjuryguidedbylysosomalviscosityactivatableniriifluorescence